Publisert 27.07.2016

Regenics AS Annual Report 2015

Regenics post a first positive 2015 result with topline in excess of 4 mill NOK. 

Regenics post a first positive annual result with topline in excess of 4 mill NOK. surplus after initiating sales of the salmon roe LEX® to domestic and international customers.  Sales of LEX to  the award winning AquaDerma series as well as public R&D funding from Eurostars and the BIA programme in Norway contributes to the result. 

Annual Report 2015  (password)  

 

 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.